Zoetis Inc receives high rating using Warren Buffett's Patient Investor model

From Nasdaq: 2025-06-14 13:04:00

Validea’s guru fundamental report for ZOETIS INC (ZTS) shows the stock rates highest using Warren Buffett’s Patient Investor model. ZTS is a large-cap growth stock in the Biotechnology & Drugs industry, with an 82% rating based on fundamentals and valuation. The strategy seeks firms with long-term profitability and low debt at reasonable valuations. ZTS passes most of the strategy’s tests, including earnings predictability, debt service, free cash flow, and more. Warren Buffett, known for his successful investing track record, is the chairman of Berkshire Hathaway and has consistently outperformed the S&P 500 over decades.



Read more at Nasdaq: ZTS Quantitative Stock Analysis – Warren Buffett